Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
6,74 USD | +1,35% | +0,75% | -46,29% |
05/06 | Transcript : Agilon health, inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-05-2024 11:20 AM | |
05/06 | Agilon Health benoemt Jeff Schwaneke tot CFO | MT |
Omzet 2024 * | 6,16 mld. 5,74 mld. | Omzet 2025 * | 7,51 mld. 6,99 mld. | Marktkapitalisatie | 2,73 mld. 2,55 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -145 mln. -135 mln. | Nettowinst (verlies) 2025 * | -67 mln. -62,4 mln. | EV/omzet 2024 * | 0,42 x |
Nettoliquiditeiten 2024 * | 169 mln. 158 mln. | Nettoliquiditeiten 2025 * | 183 mln. 171 mln. | EV/omzet 2025 * | 0,34 x |
K/w-verhouding 2024 * |
-18,6
x | K/w-verhouding 2025 * |
-35,8
x | Werknemers | 1.117 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 74,06% |
Recentste transcriptie over agilon health, inc.
1 dag | +1,35% | ||
1 week | +0,75% | ||
Lopende maand | +6,98% | ||
1 maand | +25,75% | ||
3 maanden | +24,81% | ||
6 maanden | -47,63% | ||
Lopend jaar | -46,29% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Veeral Desai
FOU | Founder | 43 | 01-01-16 |
Steven Sell
CEO | Chief Executive Officer | 57 | 01-06-20 |
Timothy Bensley
DFI | Director of Finance/CFO | 64 | 01-01-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Steven Sell
CEO | Chief Executive Officer | 57 | 01-06-20 |
Ronald Williams
FOU | Founder | 74 | 01-01-16 |
Sharad Mansukani
BRD | Director/Board Member | 54 | 01-01-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.94% | 7 M€ | 0,00% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
18-06-24 | 6,74 | +1,35% | 2 754 833 |
17-06-24 | 6,65 | -3,62% | 3 649 354 |
14-06-24 | 6,9 | 0,00% | 3 098 329 |
13-06-24 | 6,9 | +0,29% | 5 772 647 |
12-06-24 | 6,88 | +2,84% | 3 234 864 |
uitgestelde koers Nyse, 18 juni 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-46,29% | 2,73 mld. | |
-28,08% | 2,71 mld. | |
-25,53% | 2,55 mld. | |
-46,46% | 230 mln. | |
-50,52% | 165 mln. | |
-37,43% | 109 mln. |